找到约 26 条 “TH-257” 相关结果 （用时 0.112 秒）
| 目录号 | 产品名称 | 中文名称 | 靶点 |
|---|---|---|---|
| M8745 | ITH12575 | ITH12575 | Others |
| ITH12575 is apotent and selective inhibitor of mitochondrial Na+/Ca2+ exchanger mNCX with neuroprotective activity. | |||
M9499
|
TH-257 | TH-257 | LIM Kinase |
| TH257 | |||
| TH-257是一种有效的选择性变构LIMK 1/2抑制剂，对LIMK1和LIMK2的IC50值分别为84 nM和39 nM。 | |||
| M12443 | ChemBridge-5925714 | ChemBridge化合物-5925714 | Screening Compounds and Building Blocks |
| N-[3-(hydrazinocarbonyl)-2-naphthyl]benzenesulfonamide (5925714) | |||
| ChemBridge特有类药化合物/先导化合物-5925714，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M46088 | ChemBridge-7225782 | ChemBridge化合物-7225782 | Screening Compounds and Building Blocks |
| N-[4-(diethylamino)phenyl]-2-phenylbutanamide (7225782) | |||
| ChemBridge特有类药化合物/先导化合物-7225782，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M46420 | ChemBridge-7925726 | ChemBridge化合物-7925726 | Screening Compounds and Building Blocks |
| N-(5-methyl-3-isoxazolyl)-2-(5-nitro-1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)acetamide (7925726) | |||
| ChemBridge特有类药化合物/先导化合物-7925726，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M46457 | ChemBridge-7952576 | ChemBridge化合物-7952576 | Screening Compounds and Building Blocks |
| N-(5-methyl-3-isoxazolyl)-4-(2-oxo-1-pyrrolidinyl)benzenesulfonamide (7952576) | |||
| ChemBridge特有类药化合物/先导化合物-7952576，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M46732 | ChemBridge-8925722 | ChemBridge化合物-8925722 | Screening Compounds and Building Blocks |
| 5-methyl-N-(4-{[(2-methylphenyl)amino]sulfonyl}phenyl)-1,3-diphenyl-1H-pyrazole-4-carboxamide (8925722) | |||
| ChemBridge特有类药化合物/先导化合物-8925722，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M47052 | ChemBridge-9225712 | ChemBridge化合物-9225712 | Screening Compounds and Building Blocks |
| 2-methyl-9-phenyl-7-(1H-1,2,4-triazol-5-yl)pyrido[4,3-d][1,2,4]triazolo[1,5-a]pyrimidin-8(7H)-one (9225712) | |||
| ChemBridge特有类药化合物/先导化合物-9225712，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M47166 | ChemBridge-9302570 | ChemBridge化合物-9302570 | Screening Compounds and Building Blocks |
| N-(4-methoxybenzyl)-5-(2-methoxyphenyl)-3-isoxazolecarboxamide (9302570) | |||
| ChemBridge特有类药化合物/先导化合物-9302570，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M47452 | ChemBridge-17525765 | ChemBridge化合物-17525765 | Screening Compounds and Building Blocks |
| 4-[4-ethyl-5-(1H-imidazol-1-ylmethyl)-4H-1,2,4-triazol-3-yl]-1-[(isopropylthio)acetyl]piperidine (17525765) | |||
| ChemBridge特有类药化合物/先导化合物-17525765，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M47576 | ChemBridge-22062574 | ChemBridge化合物-22062574 | Screening Compounds and Building Blocks |
| N-methyl-N-[1-[1-(4-methyl-2-oxopentanoyl)-4-piperidinyl]-2-(2-methylphenyl)ethyl]-2-(1H-pyrazol-1-yl)acetamide (22062574) | |||
| ChemBridge特有类药化合物/先导化合物-22062574，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M47665 | ChemBridge-25740113 | ChemBridge化合物-25740113 | Screening Compounds and Building Blocks |
| (3aR*,9bR*)-2-(5-ethyl-2,6-dimethylpyrimidin-4-yl)-7-methoxy-1,2,3,9b-tetrahydrochromeno[3,4-c]pyrrole-3a(4H)-carboxylic acid (25740113) | |||
| ChemBridge特有类药化合物/先导化合物-25740113，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M48163 | ChemBridge-46257037 | ChemBridge化合物-46257037 | Screening Compounds and Building Blocks |
| 6-(4-methyl-3-oxopiperazin-1-yl)-N-[(3-propylisoxazol-5-yl)methyl]nicotinamide (46257037) | |||
| ChemBridge特有类药化合物/先导化合物-46257037，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M48223 | ChemBridge-48496257 | ChemBridge化合物-48496257 | Screening Compounds and Building Blocks |
| N-[(3-hydroxycyclobutyl)(6-methoxypyridin-3-yl)methyl]-6-methylimidazo[1,2-a]pyridine-2-carboxamide (48496257) | |||
| ChemBridge特有类药化合物/先导化合物-48496257，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M48420 | ChemBridge-56257359 | ChemBridge化合物-56257359 | Screening Compounds and Building Blocks |
| [1-(3-chloro-4-{[1-(methylsulfonyl)-4-piperidinyl]oxy}benzoyl)-4-piperidinyl]methanol (56257359) | |||
| ChemBridge特有类药化合物/先导化合物-56257359，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M48472 | ChemBridge-58825731 | ChemBridge化合物-58825731 | Screening Compounds and Building Blocks |
| N-[(S*)-(cis-3-hydroxycyclobutyl)(1-methyl-1H-pyrazol-4-yl)methyl]-2-(8-methylimidazo[1,2-a]pyridin-3-yl)acetamide (58825731) | |||
| ChemBridge特有类药化合物/先导化合物-58825731，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M48531 | ChemBridge-61257229 | ChemBridge化合物-61257229 | Screening Compounds and Building Blocks |
| rac-(1S,3S,7aR)-3-phenyl-N-[2-(1H-tetrazol-5-yl)ethyl]hexahydro-1H-pyrrolizine-1-carboxamide (61257229) | |||
| ChemBridge特有类药化合物/先导化合物-61257229，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M48677 | ChemBridge-67325780 | ChemBridge化合物-67325780 | Screening Compounds and Building Blocks |
| (3aS*,6aR*)-5-benzoyl-3-[2-(4-methoxyphenyl)ethyl]hexahydro-2H-pyrrolo[3,4-d][1,3]oxazol-2-one (67325780) | |||
| ChemBridge特有类药化合物/先导化合物-67325780，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M48701 | ChemBridge-68725758 | ChemBridge化合物-68725758 | Screening Compounds and Building Blocks |
| 2-(1,2,4,5-tetrahydro-3H-3-benzazepin-3-ylmethyl)benzonitrile (68725758) | |||
| ChemBridge特有类药化合物/先导化合物-68725758，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M48729 | ChemBridge-70192579 | ChemBridge化合物-70192579 | Screening Compounds and Building Blocks |
| N-methyl-6-(2-phenylpropyl)-4-(1-pyrrolidinylcarbonyl)-5,6,7,8-tetrahydropyrido[4,3-d]pyrimidin-2-amine (70192579) | |||
| ChemBridge特有类药化合物/先导化合物-70192579，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M49193 | ChemBridge-92574394 | ChemBridge化合物-92574394 | Screening Compounds and Building Blocks |
| 2,3-dimethyl-6-{[3-(3-methyl-1,2,4-oxadiazol-5-yl)pyrrolidin-1-yl]carbonyl}quinoxaline (92574394) | |||
| ChemBridge特有类药化合物/先导化合物-92574394，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M49981 | ChemBridge-82525720 | ChemBridge化合物-82525720 | Screening Compounds and Building Blocks |
| 3-methyl-N-[4-methyl-3-(propionylamino)phenyl]-4-morpholin-4-ylbenzamide (82525720) | |||
| ChemBridge特有类药化合物/先导化合物-82525720，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M49987 | ChemBridge-72598257 | ChemBridge化合物-72598257 | Screening Compounds and Building Blocks |
| 3-hydroxy-3-({[2-(methylamino)ethyl]amino}methyl)-1-(2-phenylethyl)piperidin-2-one (72598257) | |||
| ChemBridge特有类药化合物/先导化合物-72598257，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M49988 | ChemBridge-62570111 | ChemBridge化合物-62570111 | Screening Compounds and Building Blocks |
| 6-({[(6-methylimidazo[1,2-a]pyridin-2-yl)methyl]amino}methyl)-1,4-oxazepan-6-ol dihydrochloride (62570111) | |||
| ChemBridge特有类药化合物/先导化合物-62570111，由AbMole（奥默生物）独家提供。具体售价货期请咨询AbMole（奥默生物）。运费额外计算。 | |||
| M4909
|
GSK2801 | GSK2801 | Epigenetic Reader Domain |
| GSK2801 is a selective bromodomains BAZ2A/B inhibitor with KD of 257 nM and 136 nM, respectively. | |||
| M15079
|
Recombinant Human NT-3 (E.coli) | 重组人NT-3蛋白 (E.coli) | Cytokines and Growth Factors |
| Neurotrophin-3; NT-3; HDNF; Nerve Growth Factor 2 | |||
| 利用大肠杆菌表达系统制备了重组人神经营养因子-3，并表达了编码Tyr139-Thr257的目的基因。Accession #: P20783。 | |||
